UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061276
Receipt number R000070071
Scientific Title A prospective randomized controlled trial comparing working portal placement in assisted full-endoscopic spine surgery (AFESS) unilateral laminotomy with bilateral decompression for lumbar spinal stenosis, using the ipsilateral inferior articular process preservation rate as the primary endpoint
Date of disclosure of the study information 2026/04/19
Last modified on 2026/04/15 17:31:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Comparative Study of Working Portal Placement in AFESS Surgery for Lumbar Spinal Stenosis

Acronym

AFESS trial

Scientific Title

A prospective randomized controlled trial comparing working portal placement in assisted full-endoscopic spine surgery (AFESS) unilateral laminotomy with bilateral decompression for lumbar spinal stenosis, using the ipsilateral inferior articular process preservation rate as the primary endpoint

Scientific Title:Acronym

AFESS portal trial

Region

Japan


Condition

Condition

Lumbar spinal canal stenosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Primary objective:
To compare the preservation rate of the ipsilateral inferior articular process on CT obtained within 4 days after surgery between patients undergoing left-sided unilateral laminotomy with bilateral decompression using assisted full-endoscopic spine surgery (AFESS) with the working portal placed 4 mm lateral to the midline and those with the working portal placed 10 mm lateral to the midline.

Secondary objectives:
To compare between the two groups the extent of additional bone resection at the base of the ipsilateral spinous process on CT within 4 days after surgery, adverse events and reoperation from intraoperatively to 12 months postoperatively, patient-reported outcomes (VAS for low back pain, VAS for leg pain, ODI, and EQ-5D) at 3, 6, and 12 months postoperatively, and radiographic instability on plain radiographs at 12 months postoperatively.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Postoperative CT-based preservation rate (%) of the ipsilateral inferior articular process within 4 days after surgery

Key secondary outcomes

Operative time (from skin incision to completion of skin closure), Amount of additional bone resection at the base of the ipsilateral spinous process, VAS for low back pain, VAS for leg pain, ODI, and EQ-5D at 3, 6, and 12 months postoperatively, Perioperative complications (including dural injury, neurologic injury, hematoma, infection, and reoperation), Presence or absence of radiographic instability on plain radiographs at 12 months postoperatively


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Group A (lateral group): Left-sided unilateral laminotomy with bilateral decompression using AFESS. The skin incision center of the working portal is placed 10 mm lateral to the midline on the left side (allowable range, 6-14 mm). The fascia is opened longitudinally. The camera portal position, endoscope, instruments, decompression range, and perioperative management are standardized according to the institutional AFESS protocol. For safety reasons, portal relocation is allowed intraoperatively if continuation is judged difficult or unsafe.

Interventions/Control_2

Group B (medial group): Left-sided unilateral laminotomy with bilateral decompression using AFESS. The skin incision center of the working portal is placed 4 mm lateral to the midline on the left side (allowable range, 0-8 mm). The fascia is opened transversely. The camera portal position, endoscope, instruments, decompression range, and perioperative management are standardized according to the institutional AFESS protocol. For safety reasons, portal relocation is allowed intraoperatively if continuation is judged difficult or unsafe.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

・ Patients scheduled to undergo elective left-sided unilateral laminotomy with bilateral decompression using AFESS for lumbar spinal stenosis at our institution
・ Age 20 years or older
・Lumbar spinal stenosis involving 1 to 3 levels at L2/3, L3/4, L4/5, or L5/S1 (central canal stenosis and/or lateral recess stenosis), with concordance between imaging findings and symptoms and judged to require surgery
・ Insufficient improvement after conservative treatment, including medication, nerve block, and/or physical therapy
・ Able to undergo preoperative CT and MRI and routine postoperative CT evaluation within 4 days after surgery
・ Written informed consent obtained

Key exclusion criteria

・ Reoperation at the same level
・ Cases judged to require concomitant fusion surgery
・ Cases with obvious instability (posterior opening angle >10 degrees) or degenerative spondylolisthesis of Meyerding grade II or higher
・ Cases with severe ossification of the ligamentum flavum
・ Cases in which the main pathology is not degenerative disease, such as infection, tumor, trauma, or cystic lesions
・ Cases with marked degenerative scoliosis (Cobb angle >20 degrees), congenital or acquired bony deformity, or severe ossified lesions, in which standardized portal placement is expected to be difficult
・ Cases judged inappropriate by the principal investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Shota
Middle name
Last name Takenaka

Organization

Japan Community Healthcare Organization Osaka Hospital

Division name

Department of Orthopaedic Surgery

Zip code

553-0003

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

TEL

06-6441-5451

Email

show710216@gmail.com


Public contact

Name of contact person

1st name Sadaaki
Middle name
Last name Kanayama

Organization

Japan Community Healthcare Organization Osaka Hospital

Division name

Department of Orthopaedic Surgery

Zip code

553-0003

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

TEL

06-6441-5451

Homepage URL


Email

drsada@jewel.ocn.ne.jp


Sponsor or person

Institute

Japan Community Health Care Organization Osaka Hospital

Institute

Department

Personal name

Shota Takenaka


Funding Source

Organization

Japan Community Health Care Organization Osaka Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Community Health Care Organization Osaka Hospital

Address

4-2-78 Fukushima, Fukushima-ku, Osaka City, Osaka, Japan

Tel

06-6441-5451

Email

drsada@jewel.ocn.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人地域医療機能推進機構大阪病院


Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 14 Day

Date of IRB

2026 Year 04 Month 15 Day

Anticipated trial start date

2026 Year 04 Month 15 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry

2028 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 15 Day

Last modified on

2026 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070071